Bringing precision exposome medicine for complex conditions lacking biomarkers with evidence of clinical utility.
A substantial need exists for new biomarkers, especially for CNS conditions and GI disorders caused by the interplay of genetics and the environment. Extensive research in these areas has yet to result in genetic tests to guide diagnosis and treatment choices.
Our goal is to bring precision exposome medicine to patients with autism, ADHD, schizophrenia, ALS, irritable bowel syndrome, and other complex conditions lacking biomarkers with evidence of clinical utility.
A substantial need exists for new biomarkers, especially for CNS conditions and GI disorders caused by the interplay of genetics and the environment. Extensive research in these areas has yet to result in genetic tests to guide diagnosis and treatment choices.
Our goal is to bring precision exposome medicine to patients with autism, ADHD, schizophrenia, ALS, irritable bowel syndrome, and other complex conditions lacking biomarkers with evidence of clinical utility.
ASD is a neurobiological condition that affects the ways people communicate, behave, and adapt to their surroundings. ASD can also associated with anxiety and depression.
ALS destroys the neurons that control muscle movement, including breathing. As motor neurons die, muscles atrophy and weaken. Eventually, ALS patients can no longer walk, talk or breath.
ADHD reduces people’s ability to focus and makes them more active and impulsive. Early diagnosis can lead to more effective treatment.
Chronic neurological disease that can cause delusions, hallucinations, and other behavioral issues. There are effective therapies in the clinic, but the first step is diagnosis.
